- Trials with a EudraCT protocol (61)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
61 result(s) found for: Eye Cancer.
Displaying page 1 of 4.
EudraCT Number: 2007-007847-28 | Sponsor Protocol Number: DERMA-ER-DC08 | Start Date*: 2011-09-16 | |||||||||||
Sponsor Name:Universitätsklinikum Erlangen | |||||||||||||
Full Title: A multicenter, randomized, two-armed, open-label Phase III study to evaluate the adjuvant vaccination with tumor RNA-loaded autologous Dendritic Cells versus observation of patients with resected m... | |||||||||||||
Medical condition: Patients with resected uveal melanoma showing monosomy 3, free of metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000540-15 | Sponsor Protocol Number: SPON1266-14 | Start Date*: 2014-05-01 | |||||||||||
Sponsor Name:Cardiff University | |||||||||||||
Full Title: Prostaglandin F2-alpha eye drops (Bimatoprost) in thyroid eye disease: a randomised controlled double blind crossover trial | |||||||||||||
Medical condition: Graves' ophthalmopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005575-12 | Sponsor Protocol Number: BYON5667.002 | Start Date*: 2021-06-30 | ||||||||||||||||
Sponsor Name:Byondis B.V. | ||||||||||||||||||
Full Title: A multicenter, randomized, double-blind, placebo-controlled trial with a single arm run-in period to evaluate the safety and efficacy of sodium thiosulfate (BYON5667) eye drops to reduce ocular tox... | ||||||||||||||||||
Medical condition: Single arm run-in period: Patients with solid tumours (excluding gastric tumours and adenocarcinomas of the gastroesophageal junction) Randomized part of the study: patients with locally advanced ... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004200-38 | Sponsor Protocol Number: N11RFA | Start Date*: 2012-03-28 | ||||||||||||||||
Sponsor Name:NKI-AVL | ||||||||||||||||||
Full Title: Phase II study exploring safety and efficacy of the combination of ipilimumab with radiofrequency ablation (RFA) in patients with unresectable uveal melanoma liver metastasis (SECIRA-UM) | ||||||||||||||||||
Medical condition: Unresectable uveal melanoma liver metastasis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002245-12 | Sponsor Protocol Number: EORTC 18021 | Start Date*: 2005-01-27 | |||||||||||
Sponsor Name:European Organisation for the Research and Treatment of Cancer | |||||||||||||
Full Title: Intravenous versus intra-arterial fotemustine chemotherapy in patients with liver metastases from uveal melanoma: a randomized phase III study of the EORTC Melanoma Group. | |||||||||||||
Medical condition: Uveal melanomas with specific hepatic tropism | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-005039-94 | Sponsor Protocol Number: IC2019-05 | Start Date*: 2020-12-08 | |||||||||||
Sponsor Name:Institut Curie | |||||||||||||
Full Title: RETINO 2018 : Ocular conservative treatment for retinoblastoma: efficacy of the new management strategies and visual outcome. | |||||||||||||
Medical condition: Retinoblastoma | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003380-95 | Sponsor Protocol Number: CDYP688A12101 | Start Date*: Information not available in EudraCT | |||||||||||||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||||||||||||
Full Title: A Phase I/II, multi-center, open label study of DYP688 in patients with metastatic uveal melanoma (MUM) and other GNAQ/11 mutant melanomas | |||||||||||||||||||||||
Medical condition: MUM and other non-uveal, GNAQ/11 mutant melanomas | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Ongoing) NL (Ongoing) ES (Ongoing) NO (Ongoing) IT (Prematurely Ended) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004547-77 | Sponsor Protocol Number: RN03-CP-0001 | Start Date*: 2020-06-09 | |||||||||||
Sponsor Name:ReNeuron Ltd | |||||||||||||
Full Title: First-in-human Phase I/IIa, Open-Label, Prospective Study of the Safety and Tolerability of Subretinally Transplanted Human Retinal Progenitor Cells (hRPC) in Subjects with Retinitis Pigmentosa (RP) | |||||||||||||
Medical condition: Retinitis Pigmentosa | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012304-55 | Sponsor Protocol Number: 192024-038 | Start Date*: 2009-07-15 | |||||||||||
Sponsor Name:Allergan Ltd | |||||||||||||
Full Title: A One Year, Multicenter, Double-Masked, Randomized, Parallel-Group Study Assessing the Safety and Efficacy of Once Daily Application of Bimatoprost 0.03% Solution Compared to Vehicle to Treat Hypot... | |||||||||||||
Medical condition: Hypotrichosis of the eyelashes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000961-10 | Sponsor Protocol Number: NITRO Protocol | Start Date*: 2011-12-07 | |||||||||||
Sponsor Name:Royal Liverpool and Broadgreen University Hospitals Trust | |||||||||||||
Full Title: Neoadjuvant IntraviTreal Ranibizumab treatment in high risk Ocular melanoma patients: A two stage single centre Phase II single arm study (NITRO Trial) | |||||||||||||
Medical condition: Uveal Melanoma (requiring enucleation) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001060-11 | Sponsor Protocol Number: FSJD-RTB-2015 | Start Date*: 2017-08-03 | |||||||||||
Sponsor Name:Fundació Sant Joan de Déu | |||||||||||||
Full Title: A Phase I, unicentric, open and dose escalation clinical trial to evaluate the safety and the activity of the oncolytic adenovirus VCN-01 in patients with refractory retinoblastoma | |||||||||||||
Medical condition: Refractory Retinoblastoma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000742-35 | Sponsor Protocol Number: RTBAIEOP018 | Start Date*: 2021-05-05 | ||||||||||||||||||||||||||
Sponsor Name:ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA | ||||||||||||||||||||||||||||
Full Title: PROTOCOL FOR THE DIAGNOSIS AND THERAPY OF INTRAOCULAR RETINOBLASTOMA | ||||||||||||||||||||||||||||
Medical condition: Intraocular retinoblastoma | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000845-64 | Sponsor Protocol Number: CCR4085 | Start Date*: 2014-12-17 | |||||||||||
Sponsor Name:The Royal Marsden NHS Foundation Trust | |||||||||||||
Full Title: A multicentre randomised phase II study of aflibercept plus chemotherapy in patients with colorectal liver-only metastases deemed to be inoperable or unsuitable for upfront liver resection | |||||||||||||
Medical condition: colorectal cancer with liver metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003709-15 | Sponsor Protocol Number: 20050219 | Start Date*: 2006-11-08 | ||||||||||||||||
Sponsor Name:Swedish Orphan Biovitrum AB (publ) | ||||||||||||||||||
Full Title: A Double-Blind, Randomized, Placebo-controlled Study of Two Different Schedules of Palifermin (Pre- and Post Chemotherapy and Pre-Chemotherapy only) for Reduction in Severity of Oral Mucositis in S... | ||||||||||||||||||
Medical condition: Oral Mucositis Induced by High Dose Chemotherapy Cataract development associated with palifermin administration | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) HU (Completed) CZ (Completed) IE (Completed) AT (Completed) BE (Completed) FI (Completed) SE (Completed) DE (Completed) DK (Completed) IT (Completed) NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-002569-20 | Sponsor Protocol Number: BIELEFELD-Janssen-PHRCN-2017 | Start Date*: 2018-11-06 | |||||||||||
Sponsor Name:CHU Dijon Bourgogne | |||||||||||||
Full Title: A multicenter phase 2 single-arm proof-of-concept trial assessing the efficacy and safety of ustekinumab in association with prednisone, for the treatment of non-infectious severe uveitis (NISU) | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003164-50 | Sponsor Protocol Number: CEUSUM | Start Date*: 2012-10-19 | |||||||||||
Sponsor Name:OSPEDALE S. RAFFAELE DI MILANO | |||||||||||||
Full Title: CONTRAST ENHANCED ULTRASOUND (CEUS) IN UVEAL MELANOMA: QUANTITATIVE ASSESSMENT OF TUMOR RESPONSE TO GAMMA KNIFE RADIOSURGERY (GKR) | |||||||||||||
Medical condition: patients affected by uveal melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002175-28 | Sponsor Protocol Number: DACOMINT14 | Start Date*: 2014-08-04 | |||||||||||
Sponsor Name:Fondazione IRCCS Istituto Nazionale dei Tumori | |||||||||||||
Full Title: Efficacy and safety of single agent pan-HER inhibitor Dacomitinib in the treatment of locally advanced unresectable or metastatic squamous cell cancer of the skin or with clinical contraindication... | |||||||||||||
Medical condition: locally advanced unresectable or metastatic squamous cell cancer of the skin or with clinical contraindication to surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001215-37 | Sponsor Protocol Number: RG_16_211 | Start Date*: 2018-03-19 |
Sponsor Name:University of Birmingham | ||
Full Title: A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in paediatric and adult patients with Wolfram Syndrome | ||
Medical condition: Wolfram syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) PL (Ongoing) FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001849-15 | Sponsor Protocol Number: IFCT-1601 | Start Date*: 2016-08-10 | ||||||||||||||||
Sponsor Name:IFCT | ||||||||||||||||||
Full Title: A PHASE II PROSPECTIVE IMMUNE NEOADJUVANT THERAPY STUDY OF DURVALUMAB (MEDI4736) IN EARLY STAGE NON-SMALL CELL LUNG CANCER | ||||||||||||||||||
Medical condition: Stage IB (> 4 cm), II Non Small Cell Lung Cancer resectable | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-003621-10 | Sponsor Protocol Number: IC2011.05 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:INSTITUT CURIE | |||||||||||||
Full Title: CONSERVATIVE TREATMENT OF PATIENTS WITH RETINOBLASTOMA | |||||||||||||
Medical condition: RETINOBLASTOMA | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.